{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T19:24:40Z","timestamp":1773948280053,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2023,6,17]],"date-time":"2023-06-17T00:00:00Z","timestamp":1686960000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,6,17]],"date-time":"2023-06-17T00:00:00Z","timestamp":1686960000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1007\/s00417-023-06138-6","type":"journal-article","created":{"date-parts":[[2023,6,17]],"date-time":"2023-06-17T09:02:05Z","timestamp":1686992525000},"page":"3223-3229","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Pre-operative versus post-operative intravitreal aflibercept injection for management of DME in patients undergoing cataract surgery"],"prefix":"10.1007","volume":"261","author":[{"given":"Abeer M.","family":"Khattab","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sherein M.","family":"Hagras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy M.","family":"Lotfy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,6,17]]},"reference":[{"issue":"5","key":"6138_CR1","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.ophtha.2006.08.053","volume":"114","author":"SJ Kim","year":"2007","unstructured":"Kim SJ, Equi R, Bressler NM (2007) Analysis of macular edema after cataract surgery in patients with diabetes using optical coherence tomography. Ophthalmology 114(5):881\u2013889","journal-title":"Ophthalmology"},{"issue":"2","key":"6138_CR2","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1159\/000098257","volume":"221","author":"CH Meyer","year":"2007","unstructured":"Meyer CH (2007) Current treatment approaches in diabetic macular edema. Ophthalmologica 221(2):118\u2013131","journal-title":"Ophthalmologica"},{"issue":"6","key":"6138_CR3","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1136\/bjo.2005.087403","volume":"90","author":"JI Patel","year":"2006","unstructured":"Patel JI, Hykin PG, Cree IA (2006) Diabetic cataract removal: postoperative progression of maculopathy\u2013growth factor and clinical analysis. Br J Ophthalmol 90(6):697\u2013701","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"6138_CR4","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1097\/ICU.0000000000000328","volume":"28","author":"F Boscia","year":"2017","unstructured":"Boscia F, Giancipoli E, D\u2019Amico Ricci G, Pinna A (2017) Management of macular oedema in diabetic patients undergoing cataract surgery. Curr Opin Ophthalmol 28(1):23\u201328","journal-title":"Curr Opin Ophthalmol"},{"issue":"2","key":"6138_CR5","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.oret.2017.11.007","volume":"2","author":"NC Steinle","year":"2018","unstructured":"Steinle NC, Lampen SIR, Wykoff CC (2018) The intersection of diabetes mellitus and cataract surgery: current state of management. Ophthalmol Retina 2(2):83\u201385","journal-title":"Ophthalmol Retina"},{"issue":"6","key":"6138_CR6","doi-asserted-by":"publisher","first-page":"627","DOI":"10.5301\/ejo.5001053","volume":"27","author":"T Avitabile","year":"2017","unstructured":"Avitabile T, Azzolini C, Bandello F, Boscia F, De Falco S, Fornasari D et al (2017) Aflibercept in the treatment of diabetic macular edema: a review and consensus paper. Eur J Ophthalmol 27(6):627\u2013639","journal-title":"Eur J Ophthalmol"},{"issue":"5","key":"6138_CR7","doi-asserted-by":"publisher","first-page":"e022031","DOI":"10.1136\/bmjopen-2018-022031","volume":"9","author":"B Pham","year":"2019","unstructured":"Pham B, Thomas SM, Lillie E, Lee T, Hamid J, Richter T et al (2019) Anti-vascular endothelial growth factor treatment for retinal conditions: a systematic review and meta-analysis. BMJ Open 9(5):e022031","journal-title":"BMJ Open"},{"issue":"2","key":"6138_CR8","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.oret.2017.05.003","volume":"2","author":"AA Moshfeghi","year":"2018","unstructured":"Moshfeghi AA, Shapiro H, Lemmon LA, Gune S (2018) Impact of cataract surgery during treatment with ranibizumab in patients with diabetic macular edema. Ophthalmol Retina 2(2):86\u201390","journal-title":"Ophthalmol Retina"},{"issue":"5","key":"6138_CR9","doi-asserted-by":"publisher","first-page":"981","DOI":"10.2337\/db19-1121","volume":"69","author":"M Arima","year":"2020","unstructured":"Arima M, Nakao S, Yamaguchi M, Feng H, Fujii Y, Shibata K et al (2020) Claudin-5 redistribution induced by inflammation leads to anti-VEGF-resistant diabetic macular edema. Diabetes 69(5):981\u2013999. https:\/\/doi.org\/10.2337\/db19-1121","journal-title":"Diabetes"},{"issue":"2019","key":"6138_CR10","doi-asserted-by":"publisher","first-page":"2648267","DOI":"10.1155\/2019\/2648267","volume":"16","author":"LQ Zhao","year":"2019","unstructured":"Zhao LQ, Cheng JW (2019) A systematic review and meta-analysis of clinical outcomes of intravitreal anti-VEGF agent treatment immediately after cataract surgery for patients with diabetic retinopathy. J Ophthalmol 16(2019):2648267. https:\/\/doi.org\/10.1155\/2019\/2648267","journal-title":"J Ophthalmol"},{"key":"6138_CR11","doi-asserted-by":"publisher","first-page":"7945619","DOI":"10.1155\/2016\/7945619","volume":"2016","author":"E Yumusak","year":"2016","unstructured":"Yumusak E, Ornek K (2016) Comparison of perioperative ranibizumab injections for diabetic macular edema in patients undergoing cataract surgery. J Ophthalmol 2016:7945619","journal-title":"J Ophthalmol"},{"issue":"1","key":"6138_CR12","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jcrs.2008.09.019","volume":"35","author":"RA Cheema","year":"2009","unstructured":"Cheema RA, Al-Mubarak MM, Amin YM, Cheema MA (2009) Role of combined cataract surgery and intravitreal bevacizumab injection in preventing progression of diabetic retinopathy: prospective randomized study. J Cataract Refract Surg 35(1):8\u201325","journal-title":"J Cataract Refract Surg"},{"issue":"1","key":"6138_CR13","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1097\/IAE.0b013e3182979b9e","volume":"34","author":"JB Chae","year":"2014","unstructured":"Chae JB, Joe SG, Yang SJ, Lee JY, Sung KR, Kim JY et al (2014) Effect of combined cataract surgery and ranibizumab injection in postoperative macular edema in non-proliferative diabetic retinopathy. Retina 34(1):149\u2013156","journal-title":"Retina"},{"issue":"1","key":"6138_CR14","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s00417-017-3819-2","volume":"256","author":"SY Yu","year":"2018","unstructured":"Yu SY, Nam DH, Lee DY (2018) Changes in aqueous concentrations of various cytokines after intravitreal bevacizumab and subtenon triamcinolone injection for diabetic macular edema. Graefe\u2019s Arch Clin Exp Ophthalmol 256(1):39\u201347","journal-title":"Graefe\u2019s Arch Clin Exp Ophthalmol"},{"issue":"9","key":"6138_CR15","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1097\/IAE.0b013e31824bebb8","volume":"32","author":"PI Rauen","year":"2012","unstructured":"Rauen PI, Ribeiro JA, Almeida FP, Scott IU, Messias A, Jorge R (2012) Intravitreal injection of ranibizumab during cataract surgery in patients with diabetic macular edema. Retina 32(9):1799\u20131803","journal-title":"Retina"},{"issue":"9","key":"6138_CR16","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1097\/IAE.0000000000002221","volume":"39","author":"Y Feng","year":"2018","unstructured":"Feng Y, Zhu S, Skiadaresi E, McAlinden C, Tu R, Gao R et al (2018) Phacoemulsification cataract surgery with prophylactic intravitreal bevacizumab for patients with coexisting diabetic retinopathy. Retina 39(9):1720\u20131731","journal-title":"Retina"},{"key":"6138_CR17","doi-asserted-by":"publisher","first-page":"5","DOI":"10.4081\/eye.2011.e5","volume":"1","author":"MW Stewart","year":"2011","unstructured":"Stewart MW (2011) What are the half-lives of ranibizumab and aflibercept (Trap-eyeVEGF) in human eyes? Calculations with a mathematical model. Eye Reports 1:5","journal-title":"Eye Reports"},{"issue":"11","key":"6138_CR18","doi-asserted-by":"publisher","first-page":"6501","DOI":"10.1167\/iovs.15-17279","volume":"56","author":"Y Niwa","year":"2015","unstructured":"Niwa Y, Kakinoki M, Sawada T, Wang X, Ohji M (2015) Ranibizumab and aflibercept: intraocular pharmacokinetics and their effects on aqueous VEGF level in vitrectomized and non-vitrectomized macaque eyes. Invest Ophthalmol Vis Sci 56(11):6501\u20136505","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"6138_CR19","first-page":"2637","volume":"60","author":"IM Stratton","year":"2019","unstructured":"Stratton IM, Scanlon PH, Talks JS, Chakravarthy U, Mukherjee R, Ghanchi F et al (2019) Aflibercept in the real world \u2013 are the visual outcomes worse in patients with diabetic macular edema who have had a cataract operation? Invest Ophthalmol Vis Sci 60(9):2637","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"6138_CR20","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.ajo.2021.04.002","volume":"229","author":"MR Starr","year":"2021","unstructured":"Starr MR, Mahr MA, Smith WM, Iezzi R, Barkmeier AJ, Bakri SJ (2021) Outcomes of patients with active diabetic macular edema at the time of cataract surgery managed with intravitreal anti-VEGF injections. Am J Ophth 229:194\u2013199","journal-title":"Am J Ophth"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-023-06138-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-023-06138-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-023-06138-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T09:05:57Z","timestamp":1697706357000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-023-06138-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,17]]},"references-count":20,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["6138"],"URL":"https:\/\/doi.org\/10.1007\/s00417-023-06138-6","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,17]]},"assertion":[{"value":"26 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the local Medical Ethics Committee in Kuwait, and it was in accordance with the principles of the declaration of Helsinki. The study is registered in clinical trial. Gov (NCT05731089).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed written consent was obtained from all participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate and for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}